Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future

Advanced gastrointestinal (GI) malignancies are varied in presentation, prognosis, and treatment options. With the exception of resectable recurrent colorectal cancer, metastatic GI malignancies are incurable. Cytotoxic chemotherapies have been the mainstay of therapy for decades but limited extensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, Karen, Koski, Sheryl, Scarfe, Andrew, Chu, Quincy, King, Karen, Spratlin, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2010
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248127/
https://www.ncbi.nlm.nih.gov/pubmed/21317448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248127/
https://www.ncbi.nlm.nih.gov/pubmed/21317448

Ejemplares similares